证券记录 · 已归档季度
THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
18被追踪持有人
—Δ持有人
23.95M持有股份
$3.19B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 136 | +1 | 64.22M | $12.02B | +9 | −10 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.02M | — | $1.07B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Glenview Capital ✦ | 4.67M | — | $620.68M | 13.1% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.14M | — | $284.42M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 1.78M | — | $237.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.65M | — | $220.14M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 1.56M | — | $208.18M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.38M | — | $183.33M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 713.98K | — | $94.98M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Greenlight Capital (DME Capital) ✦ | 597.68K | — | $79.51M | 3.9% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 341.25K | — | $45.40M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 11 | Point72 Asset Management ✦ | 336.26K | — | $44.73M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 299.64K | — | $39.86M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 206.38K | — | $27.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 96.64K | — | $12.86M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 86.82K | — | $11.55M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 46.53K | — | $6.19M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Two Sigma Investments ✦ | 14.60K | — | $1.94M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Harris Associates (Oakmark) ✦ | 3.90K | — | $518,817 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 686 持有人, 81.68M 股份, $13.63B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 14
KERREY J ROBERT
Director · 4.03K 股 · $1.06M
Sep 14
KERREY J ROBERT
Director · 5.48K 股 · $1.44M
Sep 14
KERREY J ROBERT
Director · 2.50K 股 · $662,079
Sep 10
MARK RICHARD J
Director · 10.00K 股 · $2.63M
Aug 31
Foo Lisa Y
Officer · 24.00K 股 · $6.39M
Aug 25
Sutaria Saumya
Officer, Director · 7.90K 股 · $2.17M
Aug 25
Sutaria Saumya
Officer, Director · 17.22K 股 · $4.71M
Aug 25
Sutaria Saumya
Officer, Director · 24.88K 股 · $6.82M
Aug 24
Sutaria Saumya
Officer, Director · 36.66K 股 · $10.22M
Aug 24
Sutaria Saumya
Officer, Director · 13.34K 股 · $3.71M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Sep 04
SC 13G/A — BlackRock, Inc.
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据